Reuters logo
2 个月前
BRIEF-Mabvax Therapeutics renews agreements with CEO and CFO
2017年7月3日 / 晚上8点19分 / 2 个月前

BRIEF-Mabvax Therapeutics renews agreements with CEO and CFO

July 3 (Reuters) - Mabvax Therapeutics Holdings Inc

* Renewed agreements with CEO J. David Hansen, Paul W. Maffuid, EVP of research and development, CFO Gregory P. Hanson to extend their terms through July 1, 2020​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below